Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.
Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA new study on the efficacy and safety of Efgartigimod in adults with Post-COVID-19 POTS has been added, replacing an earlier version from August 2024.SummaryDifference1%
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check22 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference1.0%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.9%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated to version v2.10.2, with new additions from August 2024, while the previous version v2.10.0 and its May 2024 content have been removed.SummaryDifference0.7%
Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.